In a January 2026 analysis, the most-engaged Noom GLP-1 Rx Program membersthose who use the Noom app most frequentlylost 25.2% more weight, on average, by week 40, than the least-engaged members (comparing the top and bottom quartiles based on engagement)
Its proponents report that adding GIP provides a more comprehensive approach to managing diabetes and obesity
Anyone looking for a needle-free option, members transitioning from injectables, or those wanting lighter ongoing metabolic support
Riluzole, a glutamate modulator, slows cerebral glucose metabolism decline in patients with Alzheimers disease
For clients who are putting in the work and want metabolic support, this is a clinically grounded addition to their protocol